Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Plasma Therapy Market by Type (Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap), By Application (Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Plasma Therapy Market by Type (Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap), By Application (Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168053 3300 Medical Devices & Consumables 377 250 Pages 4.6 (44)
                                          

Global Plasma Therapy Market by Type (Pure PRP, Leucocytrich PRP, Leukocytrich Fibrin (PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap), By Application (Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury) And By Region (North America, Latin America, Europe Asia Pacific and Middle East & Africa) Forecast From 2021 To 2030. The global plasma therapy market is projected to grow at a CAGR of 7.2% during the forecast period from 2021-2030. The growth can be attributed to factors such as increasing awareness about the benefits of plasma therapy among patients and healthcare providers; rising incidence rates of chronic diseases such as cancer; and technological advancements in plasma therapy devices that are driving down costs associated with treatment procedures. In 2018 pure PRP accounted for a major share of 66% the global plasma therapy market which is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., followed by leucocytrich PRP which occupied 11.19%. The most application for orthopedic which occupied 70% in 2018 followed by dental which occupied 11%. North America was the largest regional market accounting for 39% share followed by Europe with 31%, Asia Pacific with 18%, Latin America with 10%, Middle East & Africa with 3%.

Some Of The Growth Factors Of This Market:

  1. Plasma therapy devices are used for treating various conditions such as arthritis, psoriasis, and skin disorders among others which will also fuel the growth of this market in the coming years.
  2. Increasing awareness about plasma therapy among physicians and patients will also boost its adoption rates in the near future due to its effectiveness in treating various ailments without any side effects or complications associated with it like chemotherapy or radiation treatment does have on patients' health condition over time.

Industry Growth Insights published a new data on “Plasma Therapy Market”. The research report is titled “Plasma Therapy Market research by Types (Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap), By Applications (Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.), By Players/Companies Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics, Plasma Therap”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Plasma Therapy Market Research Report

By Type

Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap

By Application

Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.

By Companies

Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics, Plasma Therap

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

250

Number of Tables & Figures

175

Customization Available

Yes, the report can be customized as per your need.


Global Plasma Therapy Industry Outlook


Global Plasma Therapy Market Report Segments:

The global Plasma Therapy market is segmented on the basis of:

Types

Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018., Plasma Therap

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury, Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Terumo
  2. Arthrex
  3. Zimmer Biomet
  4. DePuy Synthes
  5. EmCyte
  6. Regen Lab
  7. ISTO Biologics
  8. Cesca Therapeutics
  9. Weigao
  10. REV-MED
  11. Nuo Therapeutics
  12. Plasma Therap

Global Plasma Therapy Market Overview


Highlights of The Plasma Therapy Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Pure PRP
    2. Leucocyte-rich PRP
    3. Leukocyte-rich Fibrin (L-PRF)
    4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
    5. Plasma Therap
  1. By Application:

    1. Orthopedic
    2. Darmatology
    3. Cardiac Muscle Injury
    4. Dental
    5. Nerve Injury
    6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Plasma Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Plasma Therapy Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Plasma therapy is a type of cancer treatment that uses high-energy beams to destroy cancer cells.

Some of the major companies in the plasma therapy market are Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics, Plasma Therap.

The plasma therapy market is expected to register a CAGR of 7.2%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Plasma Therapy Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Plasma Therapy Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Plasma Therapy Market - Supply Chain
   4.5. Global Plasma Therapy Market Forecast
      4.5.1. Plasma Therapy Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Plasma Therapy Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Plasma Therapy Market Absolute $ Opportunity

5. Global Plasma Therapy Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Plasma Therapy Market Size and Volume Forecast by Type
      5.3.1. Pure PRP
      5.3.2. Leucocyte-rich PRP
      5.3.3. Leukocyte-rich Fibrin (L-PRF)
      5.3.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      5.3.5. Plasma Therap
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Plasma Therapy Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Plasma Therapy Market Size and Volume Forecast by Application
      6.3.1. Orthopedic
      6.3.2. Darmatology
      6.3.3. Cardiac Muscle Injury
      6.3.4. Dental
      6.3.5. Nerve Injury
      6.3.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Plasma Therapy Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Plasma Therapy Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Plasma Therapy Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Plasma Therapy Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Plasma Therapy Demand Share Forecast, 2019-2026

9. North America Plasma Therapy Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Plasma Therapy Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Plasma Therapy Market Size and Volume Forecast by Application
      9.4.1. Orthopedic
      9.4.2. Darmatology
      9.4.3. Cardiac Muscle Injury
      9.4.4. Dental
      9.4.5. Nerve Injury
      9.4.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Plasma Therapy Market Size and Volume Forecast by Type
      9.7.1. Pure PRP
      9.7.2. Leucocyte-rich PRP
      9.7.3. Leukocyte-rich Fibrin (L-PRF)
      9.7.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      9.7.5. Plasma Therap
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Plasma Therapy Demand Share Forecast, 2019-2026

10. Latin America Plasma Therapy Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Plasma Therapy Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Plasma Therapy Market Size and Volume Forecast by Application
      10.4.1. Orthopedic
      10.4.2. Darmatology
      10.4.3. Cardiac Muscle Injury
      10.4.4. Dental
      10.4.5. Nerve Injury
      10.4.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Plasma Therapy Market Size and Volume Forecast by Type
      10.7.1. Pure PRP
      10.7.2. Leucocyte-rich PRP
      10.7.3. Leukocyte-rich Fibrin (L-PRF)
      10.7.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      10.7.5. Plasma Therap
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Plasma Therapy Demand Share Forecast, 2019-2026

11. Europe Plasma Therapy Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Plasma Therapy Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Plasma Therapy Market Size and Volume Forecast by Application
      11.4.1. Orthopedic
      11.4.2. Darmatology
      11.4.3. Cardiac Muscle Injury
      11.4.4. Dental
      11.4.5. Nerve Injury
      11.4.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Plasma Therapy Market Size and Volume Forecast by Type
      11.7.1. Pure PRP
      11.7.2. Leucocyte-rich PRP
      11.7.3. Leukocyte-rich Fibrin (L-PRF)
      11.7.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      11.7.5. Plasma Therap
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Plasma Therapy Demand Share, 2019-2026

12. Asia Pacific Plasma Therapy Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Plasma Therapy Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Plasma Therapy Market Size and Volume Forecast by Application
      12.4.1. Orthopedic
      12.4.2. Darmatology
      12.4.3. Cardiac Muscle Injury
      12.4.4. Dental
      12.4.5. Nerve Injury
      12.4.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Plasma Therapy Market Size and Volume Forecast by Type
      12.7.1. Pure PRP
      12.7.2. Leucocyte-rich PRP
      12.7.3. Leukocyte-rich Fibrin (L-PRF)
      12.7.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      12.7.5. Plasma Therap
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Plasma Therapy Demand Share, 2019-2026

13. Middle East & Africa Plasma Therapy Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Plasma Therapy Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Plasma Therapy Market Size and Volume Forecast by Application
      13.4.1. Orthopedic
      13.4.2. Darmatology
      13.4.3. Cardiac Muscle Injury
      13.4.4. Dental
      13.4.5. Nerve Injury
      13.4.6. Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Plasma Therapy Market Size and Volume Forecast by Type
      13.7.1. Pure PRP
      13.7.2. Leucocyte-rich PRP
      13.7.3. Leukocyte-rich Fibrin (L-PRF)
      13.7.4. In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
      13.7.5. Plasma Therap
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Plasma Therapy Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Plasma Therapy Market: Market Share Analysis
   14.2. Plasma Therapy Distributors and Customers
   14.3. Plasma Therapy Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Terumo
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Arthrex
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Zimmer Biomet
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. DePuy Synthes
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. EmCyte
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Regen Lab
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. ISTO Biologics
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Cesca Therapeutics
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Weigao
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. REV-MED
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Nuo Therapeutics
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Plasma Therap
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. C

Our Trusted Clients

Contact Us